Literature DB >> 25605287

In vivo and ex vivo magnetic resonance spectroscopy of the infarct and the subventricular zone in experimental stroke.

Elena Jiménez-Xarrié1, Myriam Davila2, Sara Gil-Perotín3, Andrés Jurado-Rodríguez4, Ana Paula Candiota5, Raquel Delgado-Mederos1, Silvia Lope-Piedrafita6, José Manuel García-Verdugo3, Carles Arús2, Joan Martí-Fàbregas1.   

Abstract

Ex vivo high-resolution magic-angle spinning (HRMAS) provides metabolic information with higher sensitivity and spectral resolution than in vivo magnetic resonance spectroscopy (MRS). Therefore, we used both techniques to better characterize the metabolic pattern of the infarct and the neural progenitor cells (NPCs) in the ipsilateral subventricular zone (SVZi). Ischemic stroke rats were divided into three groups: G0 (non-stroke controls, n = 6), G1 (day 1 after stroke, n = 6), and G7 (days 6 to 8 after stroke, n = 12). All the rats underwent MRS. Three rats per group were analyzed by HRMAS. The remaining rats were used for immunohistochemical studies. In the infarct, both techniques detected significant metabolic changes. The most relevant change was in mobile lipids (2.80 ppm) in the G7 group (a 5.53- and a 3.95-fold increase by MRS and HRMAS, respectively). In the SVZi, MRS did not detect any significant metabolic change. However, HRMAS detected a 2.70-fold increase in lactate and a 0.68-fold decrease in N-acetylaspartate in the G1 group. None of the metabolites correlated with the 1.37-fold increase in NPCs detected by immunohistochemistry in the G7 group. In conclusion, HRMAS improves the metabolic characterization of the brain in experimental ischemic stroke. However, none of the metabolites qualifies as a surrogate biomarker of NPCs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25605287      PMCID: PMC4420856          DOI: 10.1038/jcbfm.2014.257

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  38 in total

Review 1.  Application of magnetic resonance to animal models of cerebral ischemia.

Authors:  M Hoehn; K Nicolay; C Franke; B van der Sanden
Journal:  J Magn Reson Imaging       Date:  2001-11       Impact factor: 4.813

2.  Reduction of the cell cycle length by decreasing G1 phase and cell cycle reentry expand neuronal progenitor cells in the subventricular zone of adult rat after stroke.

Authors:  Rui Lan Zhang; Zheng Gang Zhang; Mei Lu; Ying Wang; James J Yang; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2006-06       Impact factor: 6.200

3.  Magnetic resonance lactate and lipid signals in rat brain after middle cerebral artery occlusion model.

Authors:  Kuniaki Harada; Osamu Honmou; He Liu; Michio Bando; Kiyohiro Houkin; Jeffery D Kocsis
Journal:  Brain Res       Date:  2006-12-29       Impact factor: 3.252

4.  The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells.

Authors:  I Barba; M E Cabañas; C Arús
Journal:  Cancer Res       Date:  1999-04-15       Impact factor: 12.701

5.  Discrimination of metabolite from lipid and macromolecule resonances in cerebral infarction in humans using short echo proton spectroscopy.

Authors:  D E Saunders; F A Howe; A van den Boogaart; J R Griffiths; M M Brown
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

6.  Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro.

Authors:  J Urenjak; S R Williams; D G Gadian; M Noble
Journal:  J Neurochem       Date:  1992-07       Impact factor: 5.372

7.  Neuronal replacement from endogenous precursors in the adult brain after stroke.

Authors:  Andreas Arvidsson; Tove Collin; Deniz Kirik; Zaal Kokaia; Olle Lindvall
Journal:  Nat Med       Date:  2002-08-05       Impact factor: 53.440

8.  NMR-invisible lactate in blood plasma.

Authors:  J D Bell; J C Brown; G Kubal; P J Sadler
Journal:  FEBS Lett       Date:  1988-08-01       Impact factor: 4.124

9.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

10.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668

View more
  5 in total

Review 1.  Applications of high-resolution magic angle spinning MRS in biomedical studies I-cell line and animal models.

Authors:  Eva Kaebisch; Taylor L Fuss; Lindsey A Vandergrift; Karin Toews; Piet Habbel; Leo L Cheng
Journal:  NMR Biomed       Date:  2017-03-16       Impact factor: 4.044

2.  Brain metabolic pattern analysis using a magnetic resonance spectra classification software in experimental stroke.

Authors:  Elena Jiménez-Xarrié; Myriam Davila; Ana Paula Candiota; Raquel Delgado-Mederos; Sandra Ortega-Martorell; Margarida Julià-Sapé; Carles Arús; Joan Martí-Fàbregas
Journal:  BMC Neurosci       Date:  2017-01-13       Impact factor: 3.288

3.  Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington's Disease.

Authors:  Sara Valdeolivas; Onintza Sagredo; Mercedes Delgado; Miguel A Pozo; Javier Fernández-Ruiz
Journal:  Int J Mol Sci       Date:  2017-03-23       Impact factor: 5.923

4.  Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia.

Authors:  Hector Lafuente; Maria R Pazos; Antonia Alvarez; Nagat Mohammed; Martín Santos; Maialen Arizti; Francisco J Alvarez; Jose A Martinez-Orgado
Journal:  Front Neurosci       Date:  2016-07-12       Impact factor: 4.677

5.  DHA and therapeutic hypothermia in a short-term follow-up piglet model of hypoxia-ischemia: Effects on H+MRS biomarkers.

Authors:  Marianne Ullestad Huun; Håvard Garberg; Else Marit Løberg; Javier Escobar; Jose Martinez-Orgado; Ola Didrik Saugstad; Rønnaug Solberg
Journal:  PLoS One       Date:  2018-08-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.